HK1007108A1 - Compositions and methods for the controlled release of soluble active substances - Google Patents

Compositions and methods for the controlled release of soluble active substances

Info

Publication number
HK1007108A1
HK1007108A1 HK98106394A HK98106394A HK1007108A1 HK 1007108 A1 HK1007108 A1 HK 1007108A1 HK 98106394 A HK98106394 A HK 98106394A HK 98106394 A HK98106394 A HK 98106394A HK 1007108 A1 HK1007108 A1 HK 1007108A1
Authority
HK
Hong Kong
Prior art keywords
compositions
methods
controlled release
active substances
soluble active
Prior art date
Application number
HK98106394A
Other languages
English (en)
Inventor
P Robert Eury
Rajesh Patel
Original Assignee
Advanced Polymer Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Polymer Systems Inc filed Critical Advanced Polymer Systems Inc
Publication of HK1007108A1 publication Critical patent/HK1007108A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
HK98106394A 1990-06-20 1998-06-24 Compositions and methods for the controlled release of soluble active substances HK1007108A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54111190A 1990-06-20 1990-06-20
PCT/US1991/004313 WO1991019483A1 (fr) 1990-06-20 1991-06-17 Compositions et procedes pour la liberation controlee de substances actives solubles

Publications (1)

Publication Number Publication Date
HK1007108A1 true HK1007108A1 (en) 1999-04-01

Family

ID=24158219

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98106394A HK1007108A1 (en) 1990-06-20 1998-06-24 Compositions and methods for the controlled release of soluble active substances

Country Status (7)

Country Link
US (1) US5316774A (fr)
EP (1) EP0533799B1 (fr)
JP (1) JP3286315B2 (fr)
AU (1) AU8050791A (fr)
DE (1) DE69114006T2 (fr)
HK (1) HK1007108A1 (fr)
WO (1) WO1991019483A1 (fr)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874091A (en) * 1990-09-27 1999-02-23 L'oreal Cosmetic composition comprising a dispersion of lipid vesicles as well as melanin pigments
US5981719A (en) 1993-03-09 1999-11-09 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
FR2717388B1 (fr) * 1994-03-21 1996-11-22 Synthelabo Formes galéniques à libération prolongée du chlorhydrate d'alfuzosine.
AT403988B (de) * 1994-05-18 1998-07-27 Lannacher Heilmittel Festes orales retardpräparat
US5583162A (en) * 1994-06-06 1996-12-10 Biopore Corporation Polymeric microbeads and method of preparation
US5849327A (en) * 1994-07-29 1998-12-15 Advanced Polymer Systems, Inc. Delivery of drugs to the lower gastrointestinal tract
GB2292079B (en) * 1994-08-12 1998-07-15 Flexpharm Ltd Coated prednisolone preparation for the treatment of inflamatory bowel disease
US6107429A (en) * 1994-10-24 2000-08-22 Amcol International Corporation Process for producing an oil and water adsorbent polymer capable of entrapping solid particles and liquids and the product thereof
US5837790A (en) 1994-10-24 1998-11-17 Amcol International Corporation Precipitation polymerization process for producing an oil adsorbent polymer capable of entrapping solid particles and liquids and the product thereof
US5830967A (en) * 1994-10-24 1998-11-03 Amcol International Corporation Process for producing an oil and water adsorbent polymer capable of entrapping solid particles and liquids and the product thereof
US5712358A (en) * 1995-06-07 1998-01-27 Amcol International Corporation Process for producing an oil sorbent copolymer and the product thereof
ES2163000T3 (es) * 1996-01-16 2002-01-16 Advanced Polymer Systems Inc Suministro topico de farmacos al tracto gastrointestinal inferior.
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
CA2271652A1 (fr) * 1996-11-12 1998-05-22 Pharmacia & Upjohn Ab Element compact compose d'une pluralite de matrices poreuses en cellulose (pcm), son procede de fabrication et d'utilisation
SE9604124D0 (sv) 1996-11-12 1996-11-12 Pharmacia & Upjohn Ab Compact member, method of manufacturing and use thereof
US6048908A (en) * 1997-06-27 2000-04-11 Biopore Corporation Hydrophilic polymeric material
US6585933B1 (en) 1999-05-03 2003-07-01 Betzdearborn, Inc. Method and composition for inhibiting corrosion in aqueous systems
US6918765B1 (en) 1999-01-25 2005-07-19 Dentsply Research & Development Corp. Hydrogel dental adhesive composition, product, system, method and dispenser
ES2197600T3 (es) 1999-01-29 2004-01-01 Disphar International B.V. Composiciones farmaceuticas.
US20020004502A1 (en) * 2000-01-05 2002-01-10 Redmond H. Paul Treatment of inflammatory bowel disease
US6491953B1 (en) * 2000-01-07 2002-12-10 Amcol International Corporation Controlled release compositions and method
US6465425B1 (en) 2000-02-10 2002-10-15 Alkermes Controlled Therapeutics, Inc. Microencapsulation and sustained release of biologically active acid-stable or free sulfhydryl-containing proteins
ATE323517T1 (de) 2000-08-15 2006-05-15 Surmodics Inc Matrix zur aufnahme von arzneimitteln
US6590059B2 (en) * 2001-05-11 2003-07-08 Ap Pharma, Inc. Bioerodible polyorthoesters from dioxolane-based diketene acetals
US20030152630A1 (en) * 2001-05-11 2003-08-14 Ng Steven Y. PEG-POE, PEG-POE-PEG, and POE-PEG-POE block copolymers
US20050244498A1 (en) * 2001-09-14 2005-11-03 Biovail Laboratories, Inc. Modified-release compositions of at least one form of venlafaxine
US6524606B1 (en) * 2001-11-16 2003-02-25 Ap Pharma, Inc. Bioerodible polyorthoesters containing amine groups
EP1530505A4 (fr) * 2001-11-30 2007-09-12 Bristol Myers Squibb Co Configurations de pipettes et jeux de pipettes pour mesurer des proprietes electriques cellulaires
AU2002351388A1 (en) * 2001-12-14 2003-06-30 The University Of Wyoming Methods and compositions for controlled release of drugs
US8133501B2 (en) 2002-02-08 2012-03-13 Boston Scientific Scimed, Inc. Implantable or insertable medical devices for controlled drug delivery
US8685427B2 (en) * 2002-07-31 2014-04-01 Boston Scientific Scimed, Inc. Controlled drug delivery
US7462366B2 (en) 2002-03-29 2008-12-09 Boston Scientific Scimed, Inc. Drug delivery particle
US7094369B2 (en) * 2002-03-29 2006-08-22 Scimed Life Systems, Inc. Processes for manufacturing polymeric microspheres
US7098252B2 (en) * 2002-04-01 2006-08-29 Rohm And Haas Company Preparation of macroreticular polymers
AU2003240000A1 (en) * 2002-06-12 2003-12-31 Boston Scientific Limited Bulking agents
US8920826B2 (en) * 2002-07-31 2014-12-30 Boston Scientific Scimed, Inc. Medical imaging reference devices
US7842377B2 (en) 2003-08-08 2010-11-30 Boston Scientific Scimed, Inc. Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
US8012454B2 (en) 2002-08-30 2011-09-06 Boston Scientific Scimed, Inc. Embolization
US20040062778A1 (en) * 2002-09-26 2004-04-01 Adi Shefer Surface dissolution and/or bulk erosion controlled release compositions and devices
WO2004037305A1 (fr) * 2002-10-21 2004-05-06 Allegiance Corporation Composition de revetement pour surface en contact avec la peau d'articles elastomeriques et articles contenant ladite composition
US7883490B2 (en) 2002-10-23 2011-02-08 Boston Scientific Scimed, Inc. Mixing and delivery of therapeutic compositions
US7670627B2 (en) * 2002-12-09 2010-03-02 Salvona Ip Llc pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients
JP4170106B2 (ja) * 2003-02-04 2008-10-22 花王株式会社 多孔性粒子及び化粧料
US7976823B2 (en) * 2003-08-29 2011-07-12 Boston Scientific Scimed, Inc. Ferromagnetic particles and methods
US7901770B2 (en) * 2003-11-04 2011-03-08 Boston Scientific Scimed, Inc. Embolic compositions
CA2556753C (fr) * 2004-02-20 2014-11-25 Lifescape Biosciences Incorporated Compositions et methodes de regulation du sommeil
US20050208134A1 (en) * 2004-02-25 2005-09-22 Shlomo Magdassi Biocompatible polymeric beads and use thereof
US7736671B2 (en) * 2004-03-02 2010-06-15 Boston Scientific Scimed, Inc. Embolization
US20040224019A1 (en) * 2004-03-03 2004-11-11 Adi Shefer Oral controlled release system for targeted drug delivery into the cell and its nucleus for gene therapy, DNA vaccination, and administration of gene based drugs
US8173176B2 (en) 2004-03-30 2012-05-08 Boston Scientific Scimed, Inc. Embolization
US20050265955A1 (en) * 2004-05-28 2005-12-01 Mallinckrodt Inc. Sustained release preparations
US7311861B2 (en) * 2004-06-01 2007-12-25 Boston Scientific Scimed, Inc. Embolization
US8425550B2 (en) * 2004-12-01 2013-04-23 Boston Scientific Scimed, Inc. Embolic coils
WO2006065991A2 (fr) * 2004-12-17 2006-06-22 Dr. Reddy's Laboratories Ltd. Dispersion delivrant un agent actif
US7858183B2 (en) 2005-03-02 2010-12-28 Boston Scientific Scimed, Inc. Particles
US7727555B2 (en) 2005-03-02 2010-06-01 Boston Scientific Scimed, Inc. Particles
US7963287B2 (en) 2005-04-28 2011-06-21 Boston Scientific Scimed, Inc. Tissue-treatment methods
US8053000B2 (en) * 2005-06-07 2011-11-08 Dr. Reddy's Laboratories Limited Compositions for drug delivery
US9463426B2 (en) 2005-06-24 2016-10-11 Boston Scientific Scimed, Inc. Methods and systems for coating particles
WO2007011972A2 (fr) * 2005-07-19 2007-01-25 Inverseon, Inc. Profil pharmocinetique ameliore d'agonistes inverses beta-adrenergiques pour le traitement de maladies des voies aeriennes pulmonaires
US8007509B2 (en) 2005-10-12 2011-08-30 Boston Scientific Scimed, Inc. Coil assemblies, components and methods
US8152839B2 (en) 2005-12-19 2012-04-10 Boston Scientific Scimed, Inc. Embolic coils
US8101197B2 (en) 2005-12-19 2012-01-24 Stryker Corporation Forming coils
US7947368B2 (en) 2005-12-21 2011-05-24 Boston Scientific Scimed, Inc. Block copolymer particles
US20080020023A1 (en) 2006-07-20 2008-01-24 Shiping Wang Nonaqueous coating composition for elastomeric articles and articles containing the same
US8414927B2 (en) 2006-11-03 2013-04-09 Boston Scientific Scimed, Inc. Cross-linked polymer particles
US20110223297A1 (en) * 2010-03-12 2011-09-15 Pepsico., Inc. Anti-Caking Agent for Flavored Products
WO2013090893A1 (fr) * 2011-12-16 2013-06-20 Celanese Eva Performance Polymers, Inc. Excipients à libération contrôlée comprenant des copolymères éthylène, des éthylcelluloses et/ou des polyuréthanes thermoplastiques
JP6316944B2 (ja) * 2013-05-17 2018-04-25 スリーエム イノベイティブ プロパティズ カンパニー 重合体複合粒子からの生物活性剤の放出
CN105228820B (zh) * 2013-05-17 2017-08-29 3M创新有限公司 反应混合物、多孔粒子以及制备方法
WO2015092602A1 (fr) 2013-12-17 2015-06-25 Ranbaxy Laboratories Limited Composition pharmaceutique topique d'un rétinoïde
JP6646657B2 (ja) * 2014-10-01 2020-02-14 スリーエム イノベイティブ プロパティズ カンパニー 繊維性基材及び多孔質ポリマー粒子を含む物品及びその製造方法
CA2936746C (fr) 2014-10-31 2017-06-27 Purdue Pharma Methodes et compositions destinees au traitement du trouble de deficit d'attention
CA3016860A1 (fr) * 2016-03-07 2017-09-14 Glaxosmithkline Biologicals Sa Particules destinees a l'administration de medicament
WO2017189388A1 (fr) * 2016-04-25 2017-11-02 3M Innovative Properties Company Particules composites pour durcir des compositions de résine époxy et compositions de résine époxy durcissables et durcies préparées à l'aide des particules
CA3081177A1 (fr) * 2017-11-02 2019-05-09 Ishihara Sangyo Kaisha, Ltd. Composition pharmaceutique a liberation prolongee
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4221871A (en) * 1970-12-16 1980-09-09 Rohm And Haas Company Reticular crosslinked monovinylidene N-heterocyclic copolymer
US3991017A (en) * 1973-12-20 1976-11-09 Rohm And Haas Company Ion exchange resins derived from hybrid copolymers
CA1125698A (fr) * 1978-03-09 1982-06-15 Masaru Yoshida Methode de preparation d'une composition a base de polymere
CA1236023A (fr) * 1984-07-18 1988-05-03 Yegnaswami Raghunathan Preparations pharmaceutiques a liberation controlee
US4772475A (en) * 1985-03-08 1988-09-20 Yamanouchi Pharmaceutical Co., Ltd. Controlled-release multiple units pharmaceutical formulation
US4692462A (en) * 1985-03-18 1987-09-08 Menley & James Laboratories, Ltd. Compositions and method of controlling transdermal penetration of topical and systemic agents
US4575539A (en) * 1985-06-03 1986-03-11 E. R. Squibb & Sons, Inc. Drug delivery systems including novel interpenetrating polymer networks and method
US4690825A (en) * 1985-10-04 1987-09-01 Advanced Polymer Systems, Inc. Method for delivering an active ingredient by controlled time release utilizing a novel delivery vehicle which can be prepared by a process utilizing the active ingredient as a porogen
US4788055A (en) * 1985-12-09 1988-11-29 Ciba-Geigy Corporation Resinate sustained release dextromethorphan composition
US4940556A (en) * 1986-01-30 1990-07-10 Syntex (U.S.A.) Inc. Method of preparing long acting formulation
ZA886284B (en) * 1987-08-31 1990-04-25 Advanced Polymer Systems Inc Controlled release formulations
US4806360A (en) * 1987-10-23 1989-02-21 Advanced Polymer Systems Synthetic melanin aggregates
US4963369A (en) * 1989-01-19 1990-10-16 Wm. Wrigley Jr. Co. Gum composition containing dispersed porous beads containing active chewing gum ingredients and method

Also Published As

Publication number Publication date
DE69114006T2 (de) 1996-05-02
JPH05507494A (ja) 1993-10-28
US5316774A (en) 1994-05-31
AU8050791A (en) 1992-01-07
JP3286315B2 (ja) 2002-05-27
DE69114006D1 (de) 1995-11-23
EP0533799B1 (fr) 1995-10-18
EP0533799A4 (en) 1993-04-28
EP0533799A1 (fr) 1993-03-31
WO1991019483A1 (fr) 1991-12-26

Similar Documents

Publication Publication Date Title
HK1007108A1 (en) Compositions and methods for the controlled release of soluble active substances
HK33294A (en) Sustained release pharmaceutical compositions and the preparation of particles for use therein
IL116066A0 (en) Controlled release caffeine composition and its preparation
IL102591A0 (en) Compositions for the sustained and controlled release of medicaments and their preparation
ZA894020B (en) Controlled release pharmaceutical formulation
GB9116472D0 (en) Sustained release pharmaceutical compositions and the preparation of particles for use therein
ZA935532B (en) Crystalline amifostine compositions and methods for the preparation and use of same
ZA913751B (en) Controlled release composition
HUT53779A (en) Insecticide preparations containing phenyl-substituted heterocyclic compounds as agents and method for producing the agents
IL98508A0 (en) Water insoluble microencapsular pharmaceutical compositions and methods for the preparation thereof
GB9004950D0 (en) Controlled release formulation
HUT59319A (en) Pharmaceutical compositions with controlled release of active ingredient and process for producing same
ZA916517B (en) Optically active trialone derivatives and compositions
EP0585168A3 (en) Composition and methods for the generation of bone
IL97288A0 (en) Photosensitive formulations containing carbodiimide derivatives and processes for the preparation thereof
EP0429982A3 (en) Controlled release compositions and use
GB2211091B (en) Polyester-based composition for the controlled release of medicinal substances
HU902626D0 (en) Process for the preparation of 5-substituted 3-aryl-isoxzole derivatives and their use as pesticides
HU896610D0 (en) Herbicid composition comprising substituted-sulfonyl-urea as active ingredient and process for preparation thereof
GB9310524D0 (en) New formulations of active substances for plant protection and methods for the use thereof
IL93139A0 (en) Pharmaceutical compositions comprising suramin and methods for the use thereof
EP0564212A3 (en) Process for the preparation of arylethylamines and substituted arylethylamines
HU900600D0 (en) Herbicide compositions containing substituted sulfonyl-carbamide-derivatives and process for preparation of the agents
IL88566A (en) Composition for the reduction of phlebectasiae and its preparation
EP0489933A4 (en) Bile alcohol and drug containing the same as active ingredient

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20070617